Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Lilleby

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
World Journal of Urology|February 24, 2005
Chemotherapy in metastatic renal cell cancerWolfgang Lilleby, Sophie D Fosså
Urology Case Reports|August 28, 2019
Metastatic-directed therapy using PSMA-PET/CT at PSA relapseOscar Lilleby, Eivor Hernes, Wolfgang Lilleby
World Journal of Urology|January 20, 2024
Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancerWolfgang Lilleby, Amar Kishan, Hans Geinitz
International Journal of Radiation Oncology, Biology, Physics|December 6, 2011
Implementation of high-dose-rate brachytherapy and androgen deprivation in patients with prostate cancerWolfgang Lilleby, Gunnar Tafjord, Nils K Raabe
Acta Oncologica (Stockholm, Sweden)|March 10, 2016
Fatigue and other adverse effects in men treated by pelvic radiation and long-term androgen deprivation for locally advanced prostate cancerWolfgang Lilleby, Andreas Stensvold, Alv A Dahl
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 26, 2015
Low-dose-rate brachytherapy for low-grade prostate cancerNils Kristian Raabe, Marius Normann, Wolfgang Lilleby
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 19, 2005
[Biology and treatment options during the development of prostate cancer]Wolfgang Lilleby, Jon Sudbø, Sophie D Fosså
The Prostate|March 28, 2013
Intensity-modulated radiotherapy to the pelvis and androgen deprivation in men with locally advanced prostate cancer: a study of adverse effects and their relation to quality of lifeWolfgang Lilleby, Andreas Stensvold, Alv A Dahl
Acta Oncologica (Stockholm, Sweden)|May 22, 2014
Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-upWolfgang Lilleby, Andreas Stensvold, Alv A Dahl
Urology Case Reports|May 23, 2024
A case of severe side effects to androgen receptor inhibitor and consequently switch to radioligand therapy in early castration resistant prostate cancerAndreas Tulipan, Clemens Kratochwil, Jacob Lilleby, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
World Journal of Urology|February 24, 2005
Chemotherapy in metastatic renal cell cancerWolfgang Lilleby, Sophie D Fosså
Urology Case Reports|August 28, 2019
Metastatic-directed therapy using PSMA-PET/CT at PSA relapseOscar Lilleby, Eivor Hernes, Wolfgang Lilleby
World Journal of Urology|January 20, 2024
Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancerWolfgang Lilleby, Amar Kishan, Hans Geinitz
International Journal of Radiation Oncology, Biology, Physics|December 6, 2011
Implementation of high-dose-rate brachytherapy and androgen deprivation in patients with prostate cancerWolfgang Lilleby, Gunnar Tafjord, Nils K Raabe
Acta Oncologica (Stockholm, Sweden)|March 10, 2016
Fatigue and other adverse effects in men treated by pelvic radiation and long-term androgen deprivation for locally advanced prostate cancerWolfgang Lilleby, Andreas Stensvold, Alv A Dahl
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 26, 2015
Low-dose-rate brachytherapy for low-grade prostate cancerNils Kristian Raabe, Marius Normann, Wolfgang Lilleby
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 19, 2005
[Biology and treatment options during the development of prostate cancer]Wolfgang Lilleby, Jon Sudbø, Sophie D Fosså
The Prostate|March 28, 2013
Intensity-modulated radiotherapy to the pelvis and androgen deprivation in men with locally advanced prostate cancer: a study of adverse effects and their relation to quality of lifeWolfgang Lilleby, Andreas Stensvold, Alv A Dahl
Acta Oncologica (Stockholm, Sweden)|May 22, 2014
Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-upWolfgang Lilleby, Andreas Stensvold, Alv A Dahl
Urology Case Reports|May 23, 2024
A case of severe side effects to androgen receptor inhibitor and consequently switch to radioligand therapy in early castration resistant prostate cancerAndreas Tulipan, Clemens Kratochwil, Jacob Lilleby, et al.
Pageof 6